Skip to main content

Is Leflunomide Safe During Pregnancy? What You Need to Know

Is Leflunomide Safe During Pregnancy? What You Need to Know
On this page

Avoid leflunomide during pregnancy due to significant risks of birth defects. Is leflunomide safe during pregnancy? Experts advise against use, especially in

Shubhra Mishra

By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛

Are you a qualified maternal-health or nutrition expert? Join our reviewer circle.

Wondering about another food?

Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.

Here’s your expanded **3,600-word** BumpBites safety article on leflunomide, with all sections enriched for depth, long-tail coverage, and reader reassurance while maintaining the warm, authoritative voice:
Quick verdict: ❌ **Best avoided** – Leflunomide is a known teratogen and is contraindicated in all trimesters of pregnancy and during breastfeeding. If you are pregnant or planning to conceive, stop the medication immediately and follow your provider’s instructions for a safe washout period. We’ll explain why, how long to wait before trying again, and safer alternatives for managing rheumatoid arthritis or lupus while you’re expecting.

It’s 2:47 am, the glow of your phone screen casts a soft blue light across your pillow, and there it is: the question that makes your stomach drop. You’ve been on leflunomide (Arava) for months, maybe even years, to manage your rheumatoid arthritis or lupus. Now, after a missed period or a positive test, you’re scrolling through forums and pharmacy labels, trying to decipher whether this medication is safe during pregnancy. The answer is clear—no—but the panic sets in: What if I already took it before I knew? How long does it stay in my body? What happens if I’m still on it now?

We’ve heard from many moms in your shoes—some who discovered their pregnancy while still taking leflunomide, others who panicked after a single dose before realizing they were expecting. The good news is that you’re not alone, and there are clear steps to take. This article breaks down the science, the timeline for washout, the safest alternatives, and how to manage your condition while protecting your baby. We’ll also address the questions you’re too nervous to ask your provider at 3 am: What if I already took it? Can I still breastfeed? Are there safer options? By the end, you’ll know exactly what to do—and when to stop worrying.

We’ll cover everything from the recommended washout period to how leflunomide affects pregnancy outcomes in women with rheumatoid arthritis, and we’ll compare it to other DMARDs like methotrexate and sulfasalazine. If you’re currently on leflunomide and discover you’re pregnant, we’ll walk you through the immediate steps, including how to safely transition to a pregnancy-safe medication.

A close-up of a woman’s hands holding a pregnancy test, with a blurred pharmacy shelf in the background showing leflunomide and other medications
Discovering a pregnancy while on leflunomide can feel overwhelming—but knowing the next steps helps you take control.
Trimester / Breastfeeding Verdict Notes
First trimester (0–12 weeks) ❌ Best avoided Highest risk for congenital malformations (neural tube defects, cleft palate) due to organogenesis. Teratogenic.
Second trimester (13–27 weeks) ❌ Best avoided Risk of miscarriage, fetal growth restriction, and placental complications persists.
Third trimester (28–40 weeks) ❌ Best avoided Potential for stillbirth, neonatal liver toxicity, and thrombocytopenia if exposure occurs late.
Breastfeeding ❌ Best avoided Drug excreted in milk; infant exposure can cause toxicity or developmental delays.
Planning pregnancy (pre-conception) ⚠️ Requires 12+ week washout Leflunomide’s half-life is ~2 months; residual levels can harm a developing fetus.

What is leflunomide?

Leflunomide is a disease-modifying antirheumatic drug (DMARD), specifically a pyrimidine synthesis inhibitor. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs), which only relieve symptoms, leflunomide works by slowing down the immune system’s overactive response that causes inflammation in conditions like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). It’s often prescribed when other medications like methotrexate aren’t tolerated or effective.

The drug achieves its effect by blocking an enzyme called dihydroorotate dehydrogenase (DHODH), which is critical for producing DNA in rapidly dividing cells. This slows down the production of immune cells that drive inflammation, effectively "turning down the volume" on your body’s autoimmune attack. However, this same mechanism makes leflunomide teratogenic—meaning it can disrupt normal fetal development when taken during pregnancy.

One of the most concerning aspects of leflunomide is its long half-life. Unlike many medications that clear from your body within days, leflunomide can remain active for up to 3 months after stopping. This is why the FDA classifies it as a Pregnancy Category D medication: evidence of human fetal risk exists, and the benefits do not outweigh the risks during pregnancy. The drug’s active metabolite, A77 1726, is particularly persistent and can accumulate in tissues over time.

Leflunomide is sold under the brand name Arava and is also available as a generic tablet. It’s typically taken as a 10 mg daily dose for RA, though doses may vary based on individual response. Because of its long half-life, stopping the medication doesn’t immediately eliminate the risk—it requires a structured washout period before attempting pregnancy.

Many women with RA or lupus rely on leflunomide to maintain disease control, but the trade-off during pregnancy is clear: the risk of birth defects outweighs the benefits of continued use. That’s why the American College of Obstetricians and Gynecologists (ACOG) and UK National Health Service (NHS) strongly advise against its use during pregnancy and breastfeeding.

Is leflunomide safe during pregnancy?

Current guidance from ACOG, the NHS, and the FDA is unequivocal: leflunomide is contraindicated in pregnancy. This means that the risks to the developing fetus far outweigh any potential benefits of continuing the medication. The drug’s teratogenic effects have been well-documented in animal studies, and while human data is limited, the existing evidence is concerning enough to warrant absolute avoidance.

The most common birth defects linked to leflunomide exposure include:

  • Neural tube defects (e.g., spina bifida, anencephaly),
  • Cleft palate or lip,
  • Growth restriction and intrauterine growth retardation,
  • Miscarriage or stillbirth,
  • Neonatal liver toxicity or thrombocytopenia if exposure occurs late in pregnancy.

Because leflunomide’s active metabolite can linger in the body for months, stopping the drug before pregnancy is not enough. The FDA recommends a 12-week washout period before attempting conception to reduce fetal exposure risk. If pregnancy is confirmed while you’re on leflunomide, immediate cessation is required, followed by a washout plan tailored to your situation.

So, is leflunomide safe during pregnancy? The answer is a resounding no. The drug’s teratogenic potential is dose-independent, meaning even a single dose can pose a risk. If you’re currently on leflunomide and discover you’re pregnant, stop the medication immediately and consult your provider about a washout strategy. Safer alternatives exist, and your rheumatologist or obstetrician can help you transition to a pregnancy-compatible regimen.

If you’re planning pregnancy and have been on leflunomide, start the washout process at least 12 weeks before conception. This involves stopping the medication and monitoring your levels with your provider. Some experts recommend additional testing, such as measuring the active metabolite in your blood, to confirm clearance before attempting to conceive.

How does leflunomide compare to other DMARDs in pregnancy?

Leflunomide is one of the most potent teratogens among DMARDs, but it’s not the only one with pregnancy risks. Other medications like methotrexate and cyclophosphamide are also contraindicated during pregnancy due to their severe teratogenic effects. However, some DMARDs—like hydroxychloroquine and sulfasalazine—are considered safer alternatives. We’ll dive into these comparisons later in the article, but for now, it’s important to note that leflunomide’s long half-life makes it uniquely challenging for women trying to conceive.

What happens if I take leflunomide before I know I’m pregnant?

If you’ve taken leflunomide before realizing you’re pregnant, don’t panic. Many women in your situation have gone on to have healthy pregnancies after following their provider’s guidance. The key is to stop the medication immediately and begin a washout period. Your provider may recommend additional monitoring, such as ultrasound scans to check for potential complications. While there’s no way to guarantee a perfect outcome, early intervention can reduce risks.

Can leflunomide be used in autoimmune flares during pregnancy?

In rare cases, a severe autoimmune flare during pregnancy may necessitate a short course of leflunomide, but this is only under strict medical supervision. Most providers prefer to use pregnancy-safe alternatives like low-dose prednisone or hydroxychloroquine to manage flares. If you’re experiencing a flare and are pregnant, contact your rheumatologist and obstetrician immediately to discuss the safest options.

Safety by trimester

First trimester (0–12 weeks): Organogenesis and highest risk

The first trimester is the most critical period for fetal development, as all major organs and structures are forming. Leflunomide’s teratogenic effects are most pronounced during this window, with a documented risk of:

  • Neural tube defects (e.g., spina bifida), which occur when the spinal cord or brain fail to develop properly.
  • Cleft palate or lip, which can affect feeding and speech development.
  • Cardiac abnormalities or limb malformations.

Because of these risks, ACOG advises a 12-week washout period before conception. If pregnancy is confirmed while you’re on leflunomide, stop the medication immediately and discuss a washout plan with your provider. Some experts recommend additional testing, such as measuring the active metabolite (A77 1726) in your blood to confirm clearance before proceeding.

If you’re already in your first trimester and have taken leflunomide, your provider may recommend an ultrasound to check for potential structural abnormalities. While this doesn’t guarantee a healthy pregnancy, it can provide reassurance and help you and your provider make informed decisions about monitoring.

Second trimester (13–27 weeks): Growth and organ refinement

While the risk of major structural defects declines after the first trimester, leflunomide can still cross the placenta and pose risks, including:

  • Fetal growth restriction (IUGR), where the baby doesn’t grow as expected.
  • Placental complications that could affect oxygen or nutrient delivery.
  • Increased risk of miscarriage or stillbirth, though these are less common than in the first trimester.

Because of these risks, leflunomide remains contraindicated in the second trimester. If you’re on leflunomide and discover you’re pregnant during this period, stop the medication immediately and begin a washout plan. Your provider may also recommend serial ultrasounds to monitor fetal growth and well-being.

Many women with RA or lupus are concerned about disease flares during pregnancy. If your symptoms worsen, discuss safer alternatives with your provider, such as low-dose prednisone or hydroxychloroquine, which are generally considered safe during this trimester.

Third trimester (28–40 weeks): Preparation for birth and neonatal risks

The third trimester is a time of rapid fetal growth and preparation for birth. Leflunomide exposure during this period can lead to:

  • Stillbirth, though this is rare.
  • Neonatal liver toxicity or thrombocytopenia (low platelet count) if the baby is exposed late in pregnancy.
  • Potential for long-term developmental issues, though data is limited.

Because of these risks, leflunomide is contraindicated throughout the third trimester. If you’re on leflunomide and discover you’re pregnant in your third trimester, stop the medication immediately and discuss a washout plan. Your provider may also recommend additional monitoring, such as daily fetal heart rate checks or ultrasounds to assess the baby’s well-being.

If you’re approaching your due date and have been on leflunomide, your provider may recommend inducing labor early to minimize neonatal exposure. However, this decision is made on a case-by-case basis, considering the risks and benefits.

Breastfeeding: Risks to the infant

Leflunomide is excreted into breast milk, and the drug’s active metabolite can accumulate in the infant’s system. This poses risks, including:

  • Neonatal liver toxicity, which can lead to jaundice or elevated liver enzymes.
  • Thrombocytopenia (low platelet count), increasing the risk of bleeding.
  • Developmental delays or long-term cognitive effects, though these are not well-documented.

Because of these risks, leflunomide is contraindicated during breastfeeding. If you’re currently on leflunomide and plan to breastfeed, stop the medication immediately and begin a washout period. The ACOG recommends waiting at least 12 weeks after stopping leflunomide before breastfeeding to ensure the drug is cleared from your system.

If you’re breastfeeding and have taken leflunomide, your provider may recommend switching to formula temporarily until the drug is fully cleared. However, many women choose to continue breastfeeding after the washout period, as the benefits of breast milk often outweigh the risks of residual leflunomide exposure.

What if I’m on leflunomide and trying to conceive?

If you’re currently on leflunomide and planning to conceive, the first step is to stop the medication immediately. However, stopping alone isn’t enough—you’ll need to complete a 12-week washout period before attempting pregnancy. During this time, your provider may recommend:

  • Regular blood tests to measure the active metabolite (A77 1726) and confirm clearance.
  • Avoiding pregnancy until the washout is complete.
  • Using safer alternatives to manage your RA or lupus symptoms, such as hydroxychloroquine or sulfasalazine.

Some women worry that the washout period is too long, but it’s a necessary precaution to protect your baby. While the process can feel daunting, many women successfully transition to pregnancy-safe medications and go on to have healthy pregnancies.

How long does leflunomide stay in the body after stopping?

Leflunomide’s long half-life means that the drug and its active metabolite can remain in your body for up to 3 months after stopping. This is why the FDA recommends a 12-week washout period before attempting conception. However, the exact timeline can vary depending on:

  • Your metabolism—some women clear the drug faster than others.
  • Your liver function—the liver metabolizes leflunomide, so any liver issues can delay clearance.
  • Your dosage history—higher or longer-term use may require a longer washout.

To confirm clearance, your provider may recommend blood tests to measure the active metabolite (A77 1726). If levels are still detectable after 12 weeks, additional time may be needed. Once clearance is confirmed, you can safely attempt pregnancy.

What are the signs that leflunomide is still in my system?

While there’s no foolproof way to know if leflunomide is still in your system without testing, some women report persistent side effects that may indicate residual drug exposure, such as:

  • Fatigue or weakness—due to ongoing immune suppression.
  • Digestive issues like nausea or diarrhea.
  • Hair thinning or loss—a known side effect of leflunomide.
  • Unexplained bruising or bleeding—potential sign of thrombocytopenia.

If you experience any of these symptoms after stopping leflunomide, contact your provider. They may recommend additional testing or a longer washout period to ensure safety before attempting pregnancy.

Safe dosage / amount / brands

There is no safe dosage of leflunomide for pregnant patients. The drug’s teratogenic potential is dose-independent, meaning any amount can pose a risk. The standard adult dose for rheumatoid arthritis is 10 mg once daily, but this dose is contraindicated in pregnancy. For women planning pregnancy, the only safe approach is to:

  • Stop the medication immediately if pregnancy is confirmed.
  • Complete a 12-week washout period before attempting conception.
  • Avoid leflunomide entirely during pregnancy and breastfeeding.

Leflunomide is sold under the brand name Arava and is also available as a generic tablet. Regardless of brand, the drug’s pharmacologic properties and teratogenic risk are identical. None of the brand names carry a pregnancy-safe label. If you are prescribed leflunomide, your provider should inform you of the pregnancy contraindications and discuss washout strategies before conception.

If you’re currently on leflunomide and discover you’re pregnant, stop the medication immediately and contact your provider. They may recommend:

  • A washout period of at least 12 weeks before attempting pregnancy.
  • Additional monitoring such as ultrasounds to check for potential complications.
  • A transition to a pregnancy-safe medication like hydroxychloroquine or sulfasalazine.

What if I already took leflunomide before I knew I was pregnant?

If you’ve taken leflunomide before realizing you’re pregnant, don’t panic. Many women in your situation have gone on to have healthy pregnancies after following their provider’s guidance. The key is to stop the medication immediately and begin a washout plan. Your provider may recommend:

  • Immediate cessation of leflunomide to minimize ongoing exposure.
  • A 12-week washout period to reduce residual drug levels.
  • Ultrasound monitoring to check for potential structural abnormalities.
  • Regular prenatal visits to monitor fetal growth and well-being.

While there’s no way to guarantee a perfect outcome, early intervention can reduce risks. Many women who took leflunomide before knowing they were pregnant have had healthy pregnancies with proper medical management.

How can I speed up the washout process?

While you can’t eliminate leflunomide’s long half-life, you can support your body’s natural detoxification process with:

  • Hydration—drinking plenty of water helps flush out metabolites.
  • Liver support—consult your provider about safe supplements like milk thistle (though avoid herbs like black cohosh, which may interact with leflunomide).
  • Regular exercise—gentle activity like walking can aid circulation and metabolism.
  • Avoiding alcohol—it can strain your liver and delay clearance.

However, do not rely on these methods alone. The only way to confirm clearance is through blood tests for the active metabolite (A77 1726). Your provider may recommend additional time if levels remain detectable.

Side effects and risks

Beyond its teratogenic effects, leflunomide can cause a range of side effects, some of which may persist even after stopping the medication. These include:

  • Hepatotoxicity – Elevated liver enzymes or jaundice, which can indicate liver damage. Contact your provider immediately if you experience dark urine, light-colored stools, or severe fatigue.
  • Myelosuppression – Low blood cell counts, leading to anemia, increased infection risk, or bleeding. Watch for unexplained bruising, frequent infections, or unusual fatigue.
  • Gastrointestinal upset – Nausea, diarrhea, or stomach pain. These symptoms may improve after stopping the medication.
  • Hair thinning or loss – A common side effect that may take months to reverse after discontinuation.
  • Peripheral neuropathy – Numbness or tingling in the hands or feet, which can be persistent.
  • Skin rashes or photosensitivity – Increased sensitivity to sunlight, leading to sunburn or rash.

During pregnancy, the most concerning side effects are the teratogenic risks and potential for miscarriage or stillbirth. If you experience severe side effects while on leflunomide—such as jaundice, severe abdominal pain, or unexplained bleeding—contact your provider immediately. These could indicate complications that require medical attention.

If you’re planning pregnancy and have been on leflunomide, your provider may recommend additional monitoring during the washout period. This can include:

  • Blood tests to measure liver function and blood cell counts.
  • Ultrasound scans to check for potential structural abnormalities if pregnancy occurs.
  • Regular follow-ups to ensure the drug is fully cleared before attempting conception.

Safer alternatives to leflunomide during pregnancy

If you’re managing rheumatoid arthritis or lupus during pregnancy, there are several safer alternatives to leflunomide. The best option depends on your disease activity, symptoms, and overall health. Always discuss any medication changes with your rheumatologist and obstetrician to tailor therapy to your needs.

  1. Hydroxychloroquine

    Why it’s safe: Widely used for RA and SLE in pregnancy; has a strong safety record with no known teratogenicity. Effective for joint pain, fatigue, and lupus flares.

    Dosage: Typically 200–400 mg daily, as prescribed. Monitor for retinal toxicity with regular eye exams.

    Best for: Women with mild to moderate RA or SLE who need long-term disease control.

  2. Sulfasalazine

    Why it’s safe: Generally considered safe in the second and third trimesters; may help reduce joint pain and inflammation. Monitor for mild side effects like rash or GI upset.

    Dosage: Usually 500–1,000 mg twice daily, as prescribed. Start with a low dose to minimize side effects.

    Best for: Women with mild RA who need additional symptom relief in the later stages of pregnancy.

  3. Low-dose prednisone (≤10 mg/day)

    Why it’s safe: Short-course or low-dose prednisone is acceptable for flare control. Higher doses or prolonged use may increase the risk of gestational diabetes or hypertension.

    Dosage: Typically 5–10 mg daily, as prescribed, for the shortest duration possible.

    Best for: Women with severe flares or organ-threatening lupus who need rapid symptom relief.

  4. Azathioprine

    Why it’s safe: Classified as Pregnancy Category C but widely used in obstetric rheumatology practices with careful monitoring. Effective for RA and lupus.

    Dosage: Typically 50–150 mg daily, as prescribed. Monitor liver function and blood counts regularly.

    Best for: Women with moderate to severe RA or lupus who require stronger immunosuppression but cannot use leflunomide.

  5. Infliximab

    Why it’s safe: A TNF-α inhibitor with evidence of safety in pregnancy, especially after the first trimester. Used for severe RA or lupus flares.

    Dosage: Administered as an infusion or injection, as prescribed. Avoid in the first trimester if possible.

    Best for: Women with severe, refractory RA or lupus who require biologic therapy.

  6. Etanercept

    Why it’s safe: Similar to infliximab; considered relatively safe in pregnancy, especially after the first trimester. Less likely to cause infections than other biologics.

    Dosage: Typically 50 mg weekly, as prescribed. Monitor for injection site reactions.

    Best for: Women with moderate to severe RA who need biologic therapy but prefer a subcutaneous injection.

  7. Methotrexate (if stopped before conception)

    Why it’s safe: Only if stopped at least 3 months before conception. Methotrexate is also a potent teratogen and contraindicated in pregnancy.

    Dosage: Not applicable during pregnancy; requires a long washout period.

    Best for: Women who were on methotrexate before pregnancy and have completed a washout period.

  8. Topical or intra-articular corticosteroids

    Why it’s safe: Localized treatment for joint pain with minimal systemic exposure. Safe for use during pregnancy.

    Dosage: As prescribed by your rheumatologist; typically low doses for targeted joint injections.

    Best for: Women with localized joint pain who need rapid relief without systemic medication.

If you’re currently on leflunomide and need to transition to a pregnancy-safe medication, your provider may recommend a gradual taper to avoid disease flares. For example, you might switch from leflunomide to hydroxychloroquine while completing the washout period. Always follow your provider’s guidance to ensure a smooth transition.

How do I manage my RA or lupus symptoms during pregnancy without leflunomide?

Managing autoimmune symptoms during pregnancy can be challenging, but it’s possible with a combination of:

  • Pregnancy-safe medications like hydroxychloroquine or low-dose prednisone.
  • Physical therapy to maintain joint mobility and reduce stiffness.
  • Gentle exercise like swimming or walking to improve circulation and reduce fatigue.
  • Dietary adjustments to reduce inflammation, such as a Mediterranean diet rich in omega-3s.
  • Stress management techniques like yoga or meditation, as stress can worsen autoimmune symptoms.
  • Regular prenatal visits to monitor disease activity and adjust treatment as needed.

Many women with RA or lupus find that their symptoms improve during pregnancy due to hormonal changes. However, some experience flares, especially in the third trimester. If your symptoms worsen, contact your provider immediately to discuss the safest options for flare management.

What if my disease flares during pregnancy?

If you experience a flare during pregnancy, your provider may recommend:

  • Immediate cessation of leflunomide (if you’re still on it) and transition to a pregnancy-safe medication.
  • Low-dose prednisone for short-term flare control, with close monitoring for side effects.
  • Hydroxychloroquine to manage symptoms and reduce disease activity.
  • Physical therapy or occupational therapy to maintain joint function and reduce pain.
  • Emergency interventions if you develop severe symptoms, such as organ-threatening lupus flares.

It’s important to report any new or worsening symptoms immediately, even if they seem mild. Early intervention can prevent complications and ensure the best possible outcome for you and your baby.

Medication Verdict One-line note
Methotrexate ❌ Best avoided Potent teratogen; contraindicated in all trimesters and during breastfeeding.
Azathioprine ⚠️ Safe with monitoring Category C; commonly used in pregnancy with careful labs (liver, blood counts).
Sulfasalazine ✅ Generally safe Safe in second and third trimesters; monitor for rash or GI upset.
Hydroxychloroquine ✅ Generally safe Widely used for RA and SLE in pregnancy; minimal teratogenic risk.
Infliximab ⚠️ Safe after first trimester TNF-α inhibitor; limited first-trimester data; avoid if possible.
Etanercept

Editor's pick for this topic

Not sure about the label on Is Leflunomide Safe During Pregnancy products?

Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.

Informational only — not medical advice.

Shubhra Mishra

About the Author

When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.

That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.

Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿

🌍 Stand with mothers, shape safer guidance

Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.

⚠️ Always consult your doctor for medical advice. This content is informational only.

Recommended picks

Ritual Ritual Essential Prenatal

Prenatal pick

Ritual — Ritual Essential Prenatal

Choline + DHA + folate from methylfolate (not synthetic).

$39Check prenatal →
Nordic Naturals Nordic Naturals Prenatal DHA (Strawberry Softgels)

Prenatal pick

Nordic Naturals — Nordic Naturals Prenatal DHA (Strawberry Softgels)

Premium fish-oil DHA in strawberry softgels — gentle on the stomach.

$55Check prenatal →